Skip to main content
Clinical Trials/NCT06765772
NCT06765772
Recruiting
Not Applicable

Combined Ultrasound Guided Bilateral Rectus Sheath and Erector Spinae Plain Blocks Versus Erector Spinae Plain Block for Intra and Postoperative Analgesia in Elective Abdominoplastic Surgeries. a Randomized Controlled Double Blinded Trial.

Cairo University1 site in 1 country40 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominoplasty
Sponsor
Cairo University
Enrollment
40
Locations
1
Primary Endpoint
Primary outcome
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trail is to determine if bilateral erector spinae plane block alone can provide good perioperative analgesia for abdominoplastic surgery patients or it is better to give combined bilateral rectus sheath and erector spinae plane blocks to achieve effective intraoperative and postoperative analgesia with minimal morphine consumption in such operations in which there is an extensive surgical dissection and a high risk of respiratory problems.

Detailed Description

This study is randomized controlled trail in which 40 adult patients (male or female) scheduled for elective abdominoplastic surgeries during the study duration will be randomized into to equal groups to investigate the efficacy of erector spinae plane block alone versus the efficacy of combine use of erector spinae and rectus sheath plane block for intra and postoperative analgesia in abdominoplastic surgery patients.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
June 2025
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hassan Mohamed Ali

Professor of Anesthesia

Cairo University

Eligibility Criteria

Inclusion Criteria

  • patients Age from 21 to 60 years ,Male and female patients ,ASA I, II patients scheduled for elective abdominoplastic surgeries during the study duration.

Exclusion Criteria

  • Patient refusal, Age less than 21 and above 60 years old, ASA III, IV patients., Infection at the site of injection, Opioid addiction, Allergy to any used substances (lidocaine, bupivacaine)., Preexisting severe or uncontrolled respiratory, renal or cardiac disease. , INR more than 1.5 and platelets less than 100000.

Outcomes

Primary Outcomes

Primary outcome

Time Frame: one hour

Visual Analogue Scale (VAS) measures pain intenesity one hour after extubation

Secondary Outcomes

  • Secondary Outcome(During opration)

Study Sites (1)

Loading locations...

Similar Trials